In addition, treatment of cancer cells with the DNMT inhibitor 5-aza-2′-deoxycytidine (5-Aza-CdR) or TSA did not affect heparanase silencing, indicating that DNMTs and HDACs were unlikely to be involved in this process (Fig. 2F). Here, DNMT1 is linked to cancer.